Advisors Asset Management, Inc. Merck & Co., Inc. Transaction History

Advisors Asset Management, Inc.

$5.28 Billion
Q3 2024

A detailed history of Advisors Asset Management, Inc. transactions in Merck & Co., Inc. stock. As of the latest transaction made, Advisors Asset Management, Inc. holds 268,576 shares of MRK stock, worth $25.9 Million. This represents 0.58% of its overall portfolio holdings.

Number of Shares

268,576

Previous 270,723 0.79%

Holding current value

$25.9 Million

Previous $33.5 Million 9.0%

% of portfolio

0.58%

Previous 0.67%

27 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 08, 2024	SELL	$111.15 - $128.97 $238,639 - $276,898	-2,147 Reduced 0.79%	268,576 $30.5 Million
Q2 2024 Aug 14, 2024	SELL	$123.8 - $132.96 $4.65 Million - $5 Million	-37,594 Reduced 12.19%	270,723 $33.5 Million
Q1 2024 May 14, 2024	SELL	$113.24 - $131.95 $3.23 Million - $3.77 Million	-28,562 Reduced 8.48%	308,317 $40.7 Million
Q4 2023 Feb 14, 2024	SELL	$100.18 - $109.02 $11.1 Million - $12.1 Million	-110,845 Reduced 24.76%	336,879 $36.7 Million
Q2 2023 Aug 14, 2023	SELL	$108.61 - $118.38 $9.23 Million - $10.1 Million	-84,956 Reduced 15.95%	447,724 $51.7 Million
Q1 2023 May 12, 2023	SELL	$102.94 - $114.86 $7.53 Million - $8.4 Million	-73,126 Reduced 12.07%	532,680 $56.7 Million
Q3 2022 Nov 08, 2022	SELL	$84.53 - $94.96 $4.62 Million - $5.19 Million	-54,663 Reduced 7.5%	674,475 $58.1 Million
Q2 2022 Aug 08, 2022	SELL	$83.49 - $94.64 $2.72 Million - $3.08 Million	-32,585 Reduced 4.28%	729,138 $66.5 Million
Q1 2022 May 17, 2022	BUY	$73.51 - $82.4 $2.54 Million - $2.85 Million	34,602 Added 4.76%	761,723 $62.5 Million
Q4 2021 Feb 15, 2022	BUY	$72.28 - $90.54 $4.45 Million - $5.57 Million	61,521 Added 9.24%	727,121 $55.7 Million
Q3 2021 Nov 12, 2021	BUY	$71.68 - $78.83 $6.44 Million - $7.08 Million	89,803 Added 15.6%	665,600 $50 Million
Q2 2021 Jul 30, 2021	BUY	$70.31 - $77.77 $12.8 Million - $14.2 Million	182,204 Added 46.29%	575,797 $44.8 Million
Q1 2021 May 07, 2021	BUY	$68.86 - $81.11 $6.92 Million - $8.15 Million	100,428 Added 34.26%	393,593 $30.3 Million
Q4 2020 Feb 12, 2021	BUY	$71.77 - $79.65 $7.73 Million - $8.58 Million	107,727 Added 58.09%	293,165 $24 Million
Q3 2020 Nov 16, 2020	BUY	$73.18 - $82.95 $2.74 Million - $3.1 Million	37,383 Added 25.25%	185,438 $15.4 Million
Q2 2020 Aug 12, 2020	SELL	$70.42 - $80.13 $671,384 - $763,959	-9,534 Reduced 6.05%	148,055 $11.4 Million
Q1 2020 May 15, 2020	SELL	$63.36 - $87.82 $4.81 Million - $6.67 Million	-75,990 Reduced 32.53%	157,589 $12.1 Million
Q4 2019 Feb 14, 2020	SELL	$77.58 - $87.54 $3.59 Million - $4.05 Million	-46,288 Reduced 16.54%	233,579 $23.7 Million
Q3 2019 Nov 14, 2019	SELL	$76.08 - $82.93 $9.99 Million - $10.9 Million	-131,294 Reduced 31.93%	279,867 $23.6 Million
Q2 2019 Aug 14, 2019	SELL	$69.84 - $81.59 $8.91 Million - $10.4 Million	-127,623 Reduced 23.69%	411,161 $34.5 Million
Q1 2019 May 15, 2019	SELL	$69.58 - $79.36 $7.47 Million - $8.52 Million	-107,416 Reduced 16.62%	538,784 $44.8 Million
Q4 2018 Jan 31, 2019	SELL	$65.24 - $75.71 $307,149 - $356,442	-4,708 Reduced 0.72%	646,200 $49.4 Million
Q3 2018 Nov 15, 2018	SELL	$57.69 - $67.84 $30,287 - $35,616	-525 Reduced 0.08%	650,908 $46.2 Million
Q2 2018 Aug 15, 2018	BUY	$50.83 - $59.72 $2.34 Million - $2.74 Million	45,964 Added 7.59%	651,433 $39.5 Million
Q1 2018 May 15, 2018	BUY	$50.96 - $59.23 $1.53 Million - $1.78 Million	30,050 Added 5.22%	605,469 $32.8 Million
Q4 2017 Feb 13, 2018	BUY	$51.62 - $61.64 $740,024 - $883,671	14,336 Added 2.56%	575,419 $32.4 Million
Q3 2017 Nov 07, 2017	BUY	$58.67 - $63.13 $32.9 Million - $35.4 Million	561,083	561,083 $35.9 Million

Others Institutions Holding MRK

# of Institutions

3,821

Shares Held

1.88B

Call Options Held

15.6M

Put Options Held

13.7M

View Full List

About Merck & Co., Inc.

Ticker MRK
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 2,533,280,000
Market Cap $244B
Description
Merck & Co., Inc. operates as a healthcare company worldwide. It operates through two segments, Pharmaceutical and Animal Health. The Pharmaceutical segment offers human health pharmaceutical products in the areas of oncology, hospital acute care, immunology, neuroscience, virology, cardiovascular, and diabetes, as well as vaccine products, ...

More about MRK

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Advisors Asset Management, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Advisors Asset Management, Inc. with notifications on news.

Account

Advisors Asset Management, Inc. Merck & Co., Inc. Transaction History